Trending

Heptares

Sosei see Teva pipeline cull as an opportunity

Sosei see Teva pipeline cull as an opportunity

Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.

X

Sosei see Teva pipeline cull as an opportunity

https://pharmaphorum.com/news/sosei-loses-teva-culls-migraine-pipeline/

MSD attracts top British scientist to head up UK discovery centre

MSD attracts top British scientist to head up UK discovery centre

Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.

X

MSD attracts top British scientist to head up UK discovery centre

https://pharmaphorum.com/news/msd-attracts-top-british-scientist-head-uk-discovery-centre/

Heptares founder Henderson named joint Nobel chemistry prize winner

Heptares founder Henderson named joint Nobel chemistry prize winner

Richard Henderson, an influential figure in UK biotech research, has won the Nobel Prize for Chemistry for his

X

Heptares founder Henderson named joint Nobel chemistry prize winner

https://pharmaphorum.com/news/uks-richard-henderson-wins-nobel-chemistry-prize/

AZ pays Heptares $10m as cancer trial begins

AZ pays Heptares $10m as cancer trial begins

Phase 1 study of immuno-oncology drug candidate begins.

X

AZ pays Heptares $10m as cancer trial begins

https://pharmaphorum.com/news/az-pays-heptares-10m-cancer-trial-begins/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com